Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice
David R. Martinez, Alexandra Schäfer, Sarah R. Leist, et al.
Science (2021) Vol. 373, Iss. 6558, pp. 991-998
Open Access | Times Cited: 177

Showing 26-50 of 177 citing articles:

Challenges and developments in universal vaccine design against SARS-CoV-2 variants
Fangxin Zhao, Xiaodong Zai, Zhiling Zhang, et al.
npj Vaccines (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 56
Durability of Heterologous and Homologous COVID-19 Vaccine Boosts
Chen Tan, Ai‐ris Y. Collier, Jingyou Yu, et al.
JAMA Network Open (2022) Vol. 5, Iss. 8, pp. e2226335-e2226335
Open Access | Times Cited: 55
Breadth of SARS-CoV-2 neutralization and protection induced by a nanoparticle vaccine
Dapeng Li, David R. Martinez, Alexandra Schäfer, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 55
An antibody class with a common CDRH3 motif broadly neutralizes sarbecoviruses
Lihong Liu, Sho Iketani, Yicheng Guo, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 646
Open Access | Times Cited: 47
Instructing durable humoral immunity for COVID-19 and other vaccinable diseases
Deepta Bhattacharya
Immunity (2022) Vol. 55, Iss. 6, pp. 945-964
Open Access | Times Cited: 47
An ACE2-dependent Sarbecovirus in Russian bats is resistant to SARS-CoV-2 vaccines
Stephanie N. Seifert, Shuangyi Bai, Stephen Fawcett, et al.
PLoS Pathogens (2022) Vol. 18, Iss. 9, pp. e1010828-e1010828
Open Access | Times Cited: 45
Omicron BA.1 and BA.2 neutralizing activity elicited by a comprehensive panel of human vaccines
John E. Bowen, Kaitlin R. Sprouse, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 42
The role of vaccines in the COVID-19 pandemic: what have we learned?
Florian Krammer
Seminars in Immunopathology (2023) Vol. 45, Iss. 4-6, pp. 451-468
Open Access | Times Cited: 38
Immune imprinting and next-generation coronavirus vaccines
Chloe Qingzhou Huang, Sneha Vishwanath, George Carnell, et al.
Nature Microbiology (2023) Vol. 8, Iss. 11, pp. 1971-1985
Closed Access | Times Cited: 38
Imprinted antibody responses against SARS-CoV-2 Omicron sublineages
Young‐Jun Park, Dora Pinto, Alexandra C. Walls, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 37
Fc-mediated pan-sarbecovirus protection after alphavirus vector vaccination
Lily E. Adams, Sarah R. Leist, Kenneth H. Dinnon, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112326-112326
Open Access | Times Cited: 35
Broadly neutralizing antibodies against sarbecoviruses generated by immunization of macaques with an AS03-adjuvanted COVID-19 vaccine
Yupeng Feng, Meng Yuan, John M. Powers, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 695
Open Access | Times Cited: 34
Therapeutic and vaccine-induced cross-reactive antibodies with effector function against emerging Omicron variants
Amin Addetia, Luca Piccoli, James Brett Case, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 30
A Mosaic Nanoparticle Vaccine Elicits Potent Mucosal Immune Response with Significant Cross‐Protection Activity against Multiple SARS‐CoV‐2 Sublineages
Xiantao Zhang, Shijian Wu, Jie Liu, et al.
Advanced Science (2023) Vol. 10, Iss. 27
Open Access | Times Cited: 25
A MERS-CoV antibody neutralizes a pre-emerging group 2c bat coronavirus
Longping V. Tse, Yixuan J. Hou, Elizabeth McFadden, et al.
Science Translational Medicine (2023) Vol. 15, Iss. 715
Open Access | Times Cited: 23
The diversity of the glycan shield of sarbecoviruses related to SARS-CoV-2
Joel D. Allen, Dylan P. Ivory, Ge Song, et al.
Cell Reports (2023) Vol. 42, Iss. 4, pp. 112307-112307
Open Access | Times Cited: 22
Broad-spectrum pan-genus and pan-family virus vaccines
Chee Wah Tan, Sophie Valkenburg, Leo L. M. Poon, et al.
Cell Host & Microbe (2023) Vol. 31, Iss. 6, pp. 902-916
Open Access | Times Cited: 22
Host range, transmissibility and antigenicity of a pangolin coronavirus
Yixuan J. Hou, S. Chiba, Sarah R. Leist, et al.
Nature Microbiology (2023) Vol. 8, Iss. 10, pp. 1820-1833
Open Access | Times Cited: 21
Prefusion-stabilized SARS-CoV-2 S2-only antigen provides protection against SARS-CoV-2 challenge
Ching‐Lin Hsieh, Sarah R. Leist, Emily Happy Miller, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 10
Hybrid immunity to SARS-CoV-2 arises from serological recall of IgG antibodies distinctly imprinted by infection or vaccination
William N. Voss, Michael L. Mallory, Patrick O. Byrne, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 8, pp. 101668-101668
Open Access | Times Cited: 9
Advanced technologies for the development of infectious disease vaccines
Akash Gupta, Arnab Rudra, Kaelan Reed, et al.
Nature Reviews Drug Discovery (2024) Vol. 23, Iss. 12, pp. 914-938
Closed Access | Times Cited: 7
Molecular basis of immune evasion by the delta and kappa SARS-CoV-2 variants
Matthew McCallum, Alexandra C. Walls, Kaitlin R. Sprouse, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 52
A broadly neutralizing antibody protects against SARS-CoV, pre-emergent bat CoVs, and SARS-CoV-2 variants in mice
David R. Martinez, Alexandra Schaefer, S. Gobeil, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 43
Glycosite-deleted mRNA of SARS-CoV-2 spike protein as a broad-spectrum vaccine
Chung‐Yi Wu, Cheng‐Wei Cheng, Chih‐Chuan Kung, et al.
Proceedings of the National Academy of Sciences (2022) Vol. 119, Iss. 9
Open Access | Times Cited: 35
Principles and practical applications of structure-based vaccine design
Patrick O. Byrne, Jason S. McLellan
Current Opinion in Immunology (2022) Vol. 77, pp. 102209-102209
Open Access | Times Cited: 34

Scroll to top